Beyond Biomimetics: Pathology‐Informed Engineering Rescues Reconstituted HDL From Inflammatory Dysfunction for Sepsis Immunotherapy
ABSTRACT Biomimetic therapies hold great promise for treating intractable diseases, yet their translation is often hindered by dysfunction—the loss of intended biological function upon exposure to pathological microenvironments. This challenge is well exemplified by reconstituted high‐density lipoprotein (rHDL), a clin...